| DAADX | VEMAX | DAADX / VEMAX | |
| Total Expense Ratio | 0.43 | 0.13 | 331% |
| Annual Report Gross Expense Ratio | 0.45 | 0.13 | 346% |
| Fund Existence | 5 years | 20 years | - |
| Gain YTD | 31.891 | 11.327 | 282% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.29B | 162B | 1% |
| Annual Yield % from dividends | 2.03 | 2.32 | 87% |
| Returns for 1 year | 46.62 | 16.83 | 277% |
| Returns for 3 years | 91.91 | 57.87 | 159% |
| Returns for 5 years | N/A | 30.52 | - |
| Returns for 10 years | N/A | 88.35 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| QDTY | 38.96 | 0.31 | +0.79% |
| YieldMax Nasdaq 100 0DTE Cove CllStgyETF | |||
| EFAX | 56.24 | 0.41 | +0.73% |
| State Street®SPDR®MSCIEAFEFsslFlRsvFrETF | |||
| EMTY | 23.77 | 0.11 | +0.48% |
| ProShares Decline of the Retl Store ETF | |||
| DSMC | 44.03 | -0.05 | -0.11% |
| Distillate Small/Mid Cash Flow ETF | |||
| IHI | 55.71 | -0.17 | -0.30% |
| iShares US Medical Devices ETF | |||